| pubmed-article:19524976 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19524976 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:19524976 | lifeskim:mentions | umls-concept:C0007112 | lld:lifeskim |
| pubmed-article:19524976 | lifeskim:mentions | umls-concept:C1168327 | lld:lifeskim |
| pubmed-article:19524976 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:19524976 | lifeskim:mentions | umls-concept:C0205292 | lld:lifeskim |
| pubmed-article:19524976 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19524976 | pubmed:dateCreated | 2009-7-14 | lld:pubmed |
| pubmed-article:19524976 | pubmed:abstractText | There is debate in the literature on the role of high grade prostatic intraepithelial neoplasia as a risk factor for subsequent prostatic adenocarcinoma detection on prostatic needle biopsy. We determined whether high grade prostatic intraepithelial neoplasia on initial prostatic needle biopsy is an independent risk factor for prostatic adenocarcinoma and whether differences exist between prostatic adenocarcinoma in patients with previous high grade prostatic intraepithelial neoplasia and those with a benign diagnosis. | lld:pubmed |
| pubmed-article:19524976 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19524976 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19524976 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19524976 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19524976 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:19524976 | pubmed:issn | 1527-3792 | lld:pubmed |
| pubmed-article:19524976 | pubmed:author | pubmed-author:SrigleyJohn... | lld:pubmed |
| pubmed-article:19524976 | pubmed:author | pubmed-author:KapustaLinda... | lld:pubmed |
| pubmed-article:19524976 | pubmed:author | pubmed-author:JonesGlennG | lld:pubmed |
| pubmed-article:19524976 | pubmed:author | pubmed-author:WalkerDaniell... | lld:pubmed |
| pubmed-article:19524976 | pubmed:author | pubmed-author:MerrimenJenni... | lld:pubmed |
| pubmed-article:19524976 | pubmed:author | pubmed-author:LeungChung... | lld:pubmed |
| pubmed-article:19524976 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19524976 | pubmed:volume | 182 | lld:pubmed |
| pubmed-article:19524976 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19524976 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19524976 | pubmed:pagination | 485-90; discussion 490 | lld:pubmed |
| pubmed-article:19524976 | pubmed:meshHeading | pubmed-meshheading:19524976... | lld:pubmed |
| pubmed-article:19524976 | pubmed:meshHeading | pubmed-meshheading:19524976... | lld:pubmed |
| pubmed-article:19524976 | pubmed:meshHeading | pubmed-meshheading:19524976... | lld:pubmed |
| pubmed-article:19524976 | pubmed:meshHeading | pubmed-meshheading:19524976... | lld:pubmed |
| pubmed-article:19524976 | pubmed:meshHeading | pubmed-meshheading:19524976... | lld:pubmed |
| pubmed-article:19524976 | pubmed:meshHeading | pubmed-meshheading:19524976... | lld:pubmed |
| pubmed-article:19524976 | pubmed:meshHeading | pubmed-meshheading:19524976... | lld:pubmed |
| pubmed-article:19524976 | pubmed:meshHeading | pubmed-meshheading:19524976... | lld:pubmed |
| pubmed-article:19524976 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19524976 | pubmed:articleTitle | Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. | lld:pubmed |
| pubmed-article:19524976 | pubmed:affiliation | McMaster University, Toronto, Ontario, Canada. Jennifer.merrimen@cdha.nshealth.ca | lld:pubmed |
| pubmed-article:19524976 | pubmed:publicationType | Journal Article | lld:pubmed |
